Lonza Biologics, Plc NDCs and Package Codes
This page lists NDC package records associated with labeler code 17504 (Lonza Biologics, Plc) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.
Key stats
9
Package NDCs
5
Products
5
Active listings
0
Discontinued
5
Ingredients
0
Therapeutic classes
1
Dosage forms
0
With NADAC pricing
Portfolio
Top ingredients
By dosage form
Browse records — 5 products
| Drug / product | Billing NDC | NADAC / unit | Status | |
|---|---|---|---|---|
| Blinatumomab 55 ug/mL LIQUID | 17504-0011-01 | — | On market | View → |
| efgartigimod 20 mg/mL LIQUID | 17504-0009-01 | — | On market | View → |
| EMAPALUMAB 25 mg/ml 25 mg/mL LIQUID | 17504-0012-01 | — | On market | View → |
| NI-0501 6 mg/ml 6 mg/mL LIQUID | 17504-0007-02 | — | On market | View → |
| tisotumab 20 mg/mL LIQUID | 17504-0008-01 | — | On market | View → |
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.